1LyMwl4

50 REVISTA ARGENTINA DE CARDIOLOGÍA / VOL 83 SUPLEMENTO 2 / JUNIO 2015
65. Khot UN, Novaro GM, Popovic ZB, Mills RM, Thomas JD, Tuzcu
EM, et al. Nitroprusside in critically ill patients with left ventricular
dysfunction and aortic stenosis. N Engl J Med 2003;348:1756-63.
66. Albertal J, Weinschelbaum E, Nojek C, Navia J. Estudio multicéntrico
de cirugía cardíaca (ESMUCICA): pacientes valvulares. Rev
Argent Cardiol 2001;69:68-79.
67. Stutzbach P, Rodríguez C, Dulbecco E, Abud J, Machain A, Gabe
E y cols. Estenosis aórtica severa: poblaciones de riesgo para el tratamiento
quirúrgico. Rev Argent Cardiol 2000;69:608-15.
68. Lowenstein Haber D, Guardiani F, Pieroni P, Pfister L, Carrizo L,
Villegas E, Renedo MF, Landeta F, Thierer J. Realidad de la cirugía
cardíaca en la República Argentina. Registro CONAREC XVI. Rev
Argent Cardiol 2010;78:228-37.
69. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural
history of adults with asymptomatic, hemodynamically significant
aortic stenosis. J Am Coll Cardiol 1990;15:1012-7.
70. Brown ML, Pellikka PA, Schaff HV, Scott CG, Mullany CJ, Sundt
TM, Dearani JA, Daly RC, Orszulak TA. The benefits of early valve
replacement in asymptomatic patients with severe aortic stenosis. J
Thorac Cardiovasc Surg 2008;135:308-15.
71. Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G,
Graf S, et al. Natural history of very severe aortic stenosis. Circulation
2010;121:151-6.
72. Kang DH, Park SJ, Rim JH, Yun SC, Kim DH, Song JM, et al.
Early surgery versus conventional treatment in asymptomatic very
severe aortic stenosis. Circulation 2010;121:1502-9.
73. Monin JL, Lancellotti P, Monchi M, Lim P, Weiss E, Pierard L, et
al. Risk score for predicting outcome in patients with asymptomatic
aortic stenosis. Circulation 2009;120:69-75.
74. Lancellotti P, Moonen M, Magne J, O’Connor K, Cosyns B, Attena
E, et al. Prognostic effect of long-axis left ventricular dysfunction and
B-type natriuretic peptide levels in asymptomatic aortic stenosis. Am
J Cardiol 2010;105:383-8.
75. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G,
Gabriel H, et al. Natriuretic peptides predict symptom-free survival
and postoperative outcome in severe aortic stenosis. Circulation
2004;109:2302-8.
76. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR,
Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically
significant aortic stenosis during prolonged follow-up.
Circulation 2005;111:3290-5.
77. Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural
history of asyntomatic severe aortic stenosis: benefit of aortic valve
replacement. Ann Thorac Surg 2006;82:2116-22.
78. Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick
T, Griffin B, et al. Coronary artery disease and outcomes of aortic
valve replacemente for severe aortic stenosis. J Am Coll Cardiol
2013;61:837-48.
79. Malouf J, Le Tourneau T, Pellikka P, Sundt TM, Scott C, Schaff
HV, et al. Aortic valve stenosis in community medical practice: Determinants
of outcome and implications for aortic valve replacement.
J Thorac Cardiovasc Surg 2012;144:1421-7.
80. Mihaljevic T, Nowicki ER, Rajeswaran J, Blackstone EH, Lagazzi
L, Thomas J, Lytle B, Cosgrove DM. Survival after valve replacement
for aortic stenosis: implications for decision making. J Thorac
Cardiovasc Surg 2008;135:1270-9.
81. Cioffi G, Faggiano P, Vizzardi E, Tarantini L, Cramariuc D, Gerdts
E, et al. Prognostic effect of inappropriately high left ventricular
mass in asymptomatic severe aortic stenosis. Heart 2011;97:301-7.
82. Maréchaux S, Hachicha Z, Bellouin A, Dumesnil JG, Meimoun P,
Pasquet A, et al. Usefulness of exercise-stress echocardiography for
risk stratification of true asymptomatic patients with aortic valve
stenosis. Eur Heart J 2010;31:1390-7.
83. Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The
emerging role of exercise testing and stress echocardiography in
valvular heart disease. J Am Coll Cardiol 2009;54:2251-60.
84. Lancellotti P, Lebois F, Simon M, Tombeux C, Chauvel C, Pierar
LA. Prognostic importance of quantitative exercise doppler echocardiography
in asymptomatic valvular aortic stenosis. Circulation
2005;112(Suppl I):I-377-I-382.
85. Lancellotti P, Magne J, Donal E, O’Connor K, Dulgheru R, Rosca
M, et al. Determinants and prognostic significance of exercise pulmonary
hypertension in asymptomatic severe aortic stenosis. Circulation
2012;126:851-9.
86. Marechaux S, Ennezat PV, Lejemtel TH, Polge AS, de Groote
P, Asseman P, et al. Left ventricular response to excercise in aortic
stenosis: an exercise echocardiographic study. Echocardiography
2007;24:955-9.
87. Donal E, Bergerot C, Thibault H, Ernande L, Loufoua J, Augeul
L, et al. Influence of afterload on left ventricular radial and longitudinal
systolic functions: a two-dimensional strain imaging study. Eur
J Echocardiogr 2009;10:914-21.
88. Lancellotti P, Donal E, Magne J, O’Connor K, Moonen ML, Cosyns
B, et al. Impact of global left ventricular afterload on left ventricular
function in asymptomatic severe aortic stenosis: a two-dimensional
speckle tracking study. Eur J Echocardiogr 2010;11:537-43.
89. Ng AC, Delgado V, Bertini M, Antoni ML, van Bommel RB, van Rijnsoever
E, et al Alterations in multidirectional myocardial functions
in patients with aortic stenosis and preserved ejection fraction: a twodimensional
speckle tracking analysis. Eur Heart J 2011;32:1542-50.
90. Tongue A, Dumesnil JG, Laforest I, Theriault C, Durand LG,
Pibarot P. Left ventricular longitudinal shortening in patients with
aortic stenosis: relationship with symptomatic status. J Heart Valve
Dis 2003;12:142-9.
91. Lafitte S, Perlant M, Reant P, Serri K, Douard H, De Maria A, et
al. Impact of impaired myocardial deformations on exercise tolerance
and prognosis in patients with asymptomatic aortic stenosis. Eur J
Echocardiogr 2009;10:414-9.
92. García Rubira J, López V, Cubero J. Coronary arterial disease in patients
with severe isolated aortic stenosis. Int J Cardiol 1992;35:121-2.
93. Gould K. Why angina pectoris in aortic stenosis. Circulation
1997;95:790-2.
94. Vaile JC, Griffith MJ. Management of asymptomatic aortic stenosis:
masterly inactivity but cut-like observation. Heart 1997;78:215-7.
95. Fiore AC, Swartz MT, Naunheim KS, Moroney DA, Canvasser DA,
McBride LR, et al. Management of asymptomatic mild aortic stenosis
during coronary artery operations. Ann Thorac Surg 1996;61:1693-8.
96. Hoff S, Merrill W, Stewart J, Bender W. Safety of remote aortic
valve replacement after prior coronary artery bypass grafting. Ann
Thorac Surg 1996;61:1689-91.
97. Peterson G, Hochrein J, Harrison K, Bashore T. Managing clinically
insignificant aortic valve disease in patients undergoing CABG.
ACC Curr Jl Rev 1997;6:61-4.
98. Pereira JJ, Balaban K, Lauer MS, Lytle B, Thomas JD, Garcia MJ.
Aortic valve replacement in patients with mild or moderate aortic
stenosis and coronary bypass surgery. Am J Med 2005;118:735-42.
99. Lababidi Z, Wu JR, Walls JT. Percutaneous balloon aortic valvuloplasty:
Results in 23 patients. Am J Cardiol 1984;53:194-7.
100. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous
transluminal valvuloplasty of acquired aortic stenosis in elderly
patients: An alternative to valve replacement? Lancet 1986;1:63-7.
101. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter
implantation of an aortic valve prosthesis for calcific aortic
stenosis: First human description. Circulation 2002;106:3006-8.
102. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C,
Levang OW, et al. A prospective survey of patients with valvular heart
disease in Europe. The Euro Heart Survey on Heart Valve Disease.
Eur Heart J 2003;24:1231-43.
103. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson
LG, et al; PARTNER Trial Investigators. Transcatheter aortic-valve
implantation for aortic stenosis in patients who cannot undergo
surgery. N Engl J Med 2010;363:1597-607.
104. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG,
Makkar RR, et al; PARTNER Trial Investigators. Two-year outcomes
after transcatheter or surgical aortic-valve replacement. N Engl J
Med 2012;366:1686-95.